Monday, 19. Sept.

10:45  Chair:   Sergio Papa (Bari IT, papabchm@cimedoc.uniba.it)

                                      Patrick Schrauwen (Maastricht NL, p.schrauwen@hb.unimaas.nl)

10:50-12:05    Oral presentations 10+5 min

10-01.       10:50-11:00

Patrick Schrauwen (Maastricht NL) Oxidative capacity, lipotoxicity and mitochondrial function in type 2 diabetes mellitus.

10-02.       11:05-11:15

Rolf Berge (Bergen NO) Dissipating excess energy in the liver is a potential treatment strategy for the metabolic syndrome.

10-03.       11:20-11:30

Wolfgang F Graier (Graz AT) Endothelial mitochondria exhibit an initial target of hyperglycemia.

10-04.       11:35-11:45

Sergio Papa (Bari IT) Complex I and physiopathology of mitochondrial oxygen metabolism.

10-05.       11:50-12:00

Josef Houstek (Prague CZ) Two components in pathogenic mechanism of mitochondrial ATPase deficiency: Energy deprivation and ROS production.

10-06.       Poster E3

Werner JH Koopmanm (Nijmegen NL) Trolox restores aberrant mitochondrial morphology and improves assembly and activity of complex I in patients with an isolated deficiency.

10-07.       Poster E4

Petr Pecina (Prague CZ) Cytochrome c oxidase assembly defects. [YIP]

10-08.       Poster E5

Karl Johan Tronstad (Bergen NO) Mitochondrial alterations during apoptosis induced by a thia fatty acid in leukemia cells.

10-09.       Poster E6

Roberto Scatena (Rome IT) Mitochondrial derangement induced by PPAR-ligands in HEP-G2 cell lines. Pathophysiological and pharmacotoxicological implications.

10-10.       Poster E7

Hong Kyu Lee (Seoul KR) Cancer cell growth can be affected by different mitochondrial DNAs from subjects without cancer.

10-11.       Poster E8

Denis Pierron (Bordeaux FR) Importance of the mitochondrial genetic background in the mtDNA mutations expression: Implication in mitochondrial diseases. [YIP]

10-12.       Poster E9

Cenk Aral (Istanbul TR) A novel approach for rapid screening of mitochondrial D310 polymorphism. [YIP]

10-13.       Poster E10

Flemming Dela (Copenhagen DK) Reduced skeletal muscle mitochondrial O2 flux capacity in type 2 diabetes.

[back]